Talk:Femarelle

This is the talk page for discussing improvements to the Femarelle article.
This is not a forum for general discussion of the article's subject.

Put new text under old text. Click here to start a new topic.
New to Wikipedia? Welcome! Learn to edit; get help.

Article policies

Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL

Individuals with a conflict of interest, particularly those representing the subject of the article, are strongly advised not to directly edit the article. See Wikipedia:Conflict of interest. You may request corrections or suggest content here on the Talk page for independent editors to review, or contact us if the issue is urgent.

This article was nominated for deletion on 28 July 2015. The result of the discussion was keep.

The following Wikipedia contributor has declared a personal or professional connection to the subject of this article. Relevant policies and guidelines may include conflict of interest, autobiography, and neutral point of view.

Korazim (talk · contribs) / Femarelle This user has contributed to the article. (declared real world identity here; per linkedin Ofir worked in Business Development for Secure Pharmaceuticals from January 2008 – October 2008 where his role was "Initiation and development of a direct B2C online sales channel, and creation on an implementation plan for distributors abroad."; he created this article in July 2008)

The following Wikipedia contributor has declared a personal or professional connection to the subject of this article. Relevant policies and guidelines may include conflict of interest, autobiography, and neutral point of view.

Corin at Secure (talk · contribs) / Femarelle (DT56a) Femarelle (DT56a) This user has declared a connection. (COI declared via username)

The following Wikipedia contributor may be personally or professionally connected to the subject of this article. Relevant policies and guidelines may include conflict of interest, autobiography, and neutral point of view.

קוריןבןקים (talk · contribs) / Femarelle (DT56a) Femarelle (DT56a) (sock of Corin at Secure; new editor mistake)

Not enough information in this article

Hello, This article has almost no information what so ever. Wikipedia is a tool used to help people get an idea about things they don't know about, a tool to get information. You deleted almost every reference i added before, Why did you? In addition to all, you gave no information of the "mode of action" of the supplement, no information of the positive effects of use, not enough information what so ever, good or bad. I believe it is important to inform the articles writer that:

1. The legal regulations for marketing/presenting of such supplements are different i US, EU and in other parts of the world. the writer's EU-POV in this article is geocentrical and therefore not in line with W-policies.

2. As W prefers review articles as a source for medical and health information, it is important to draw the writer's attention to such an article with specific references to Femarelle: S. Bedell. et al., The pros and cons of plant estrogen for menopause, J. Steroid Biochem. Mol. Biol. (2013). http://dx.doi.org/10.1016/j.jsbmb.2012.12.004

3. the writer has removed so called «inappropriate categories» from the article, while another article on a SERM the writer has edited (Menerba) still are categorized in Menopause, SERMs, Herbalism and Botanial drugs. Why are these products treated differently?

Thank you. — Preceding unsigned comment added by קוריןבןקים (talk • contribs) 06:21, 21 July 2015 (UTC)[reply]

Thanks for providing that reference. I'll have a look at it later today. Jytdog (talk) 12:22, 21 July 2015 (UTC)[reply]

Femarelle (DT56A) clarifications

Thank you for your information (Jytdog), I have read the COI link that you sent me, i support it, although i didn't try to sell or promote the product through Wikipedia. The information and references that you shared in the article on Femarelle were incorrect,you may check it again. now, the Femarelle article is very narrow and does not contain very much information, positive,negative or informative. It might as well be deleted from Wikipedia. All i am trying to write here is that the article should be adjusted with the correct information and refernces, it should be edited once again and with accurate in-depth and informative, Every time i edited this article with published scientific work you for some reason deleted my work. I am about to upload all the scientific data known to date, if for any reason something might seem incorrect, you are invited to edit it based on published scientific data. Therefore, i am asking you, or any other medical editors with no COI to re-edit Femarelle article, with the correct information and references.

Thank you.

Corin at Secure (talk) 06:27, 22 July 2015 (UTC)corin at secure[reply]

Please don't add in-depth information. This is an encycloedia and so we should instead be summarizing accepted knowledge. If readers want "in depth" then can simply consult the excellent reliable sources that we (should) cite. Alexbrn (talk) 06:33, 22 July 2015 (UTC)[reply]

I added content based on the reference you provided above. That was a recent review, which is the kind of source we use for health content. Please do read WP:MEDRS - that is our guideline for sourcing health content. Thanks again for talking. Jytdog (talk) 10:58, 22 July 2015 (UTC)[reply]

Edit request

This edit request by an editor with a conflict of interest was declined. Some or all of the changes weren't supported by neutral, independent, reliable sources. Consider re-submitting with content based on media, books and scholarly works.

Hello, What about this reference? ^[1] Was published at Journal of Clinical & Experimental Obstetrics & Gynecology, Therefore, this reference is strong enough to point out without a doubt that Femarelle contributes to bone health , Femarelle IS a SERM and does not appear to change the hormonal blood profile. could you please update this information?

References

^ Yoles I, Yogev Y, Frenkel Y, Hirsch M, Nahum R, Kaplan B (2004). "Efficacy and safety of standard versus low-dose Femarelle (DT56a) for the treatment of menopausal symptoms". Clin Exp Obstet Gynecol 31 (2): 123–6.Source: Journal of Clinical & Experimental Obstetrics & Gynecology

--Corin at Secure (talk) 07:33, 23 July 2015 (UTC)corin at secure[reply]

Not done Have you read WP:MEDRS? This is a primary source - we almost never use those for statements concerning human health. Alexbrn (talk) 07:43, 23 July 2015 (UTC)[reply]

Corin, even the review article you provided above, says that Femarelle "may be a SERM". Not, "is a SERM". And likewise, the paragraph on the clinical testing that I added based on the review, is all directly supported by the review. This is why we rely on independent review articles (per MEDRS) - they evaluate the evidence in ways that we can not, as WP editors. Jytdog (talk) 11:10, 23 July 2015 (UTC)[reply]

[1] Yoles I, Yogev Y, Frenkel Y, Hirsch M, Nahum R, Kaplan B (2004). "Efficacy and safety of standard versus low-dose Femarelle (DT56a) for the treatment of menopausal symptoms". Clin Exp Obstet Gynecol 31 (2): 123–6.Source: Journal of Clinical & Experimental Obstetrics & Gynecology

[1]